Skip to main content

Table 3 PaCO2 alteration at the end of dura suspension compared to before surgery

From: High-flow nasal cannula improves clinical efficacy of airway management in patients undergoing awake craniotomy

Group

Sample

Number

Difference

(Mean ± SD)

Median

(Interquartile range)

P value

HFNC 40

22

10.80 ± 4.40

10.75 (6.50,13.90)

< 0.001a

HFNC 60

20

10.60 ± 3.91

11.00 (6.95,12.85)

< 0.001a

NPA

23

12.25 ± 5.10

12.50 (8.10,14.90)

< 0.001a

  1. aCompared to the value before surgery. HFNC: high-flow nasal cannula
  2. NPA nasopharyngeal airway